IN8BIOINAB
13F holders, Q3 2025 (September 30)18holders +7
8new positions
1sold out
1famous investor
$2.17avg. 13F price*
At the end of Q3 2025, 18 institutions reported holding IN8BIO Inc. (INAB) in their 13F filings, up 7 from Q2 2025. 8 opened new positions and 1 sold out. The largest holders were Franklin Resources Inc. ($412K), Stonepine Capital Management, LLC ($346K) and Alyeska Investment Group, L.P. ($179K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- IN8BIO Inc.
- CUSIP
- 45674E208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $384K |
| Exits | 1 | $313K |
All 13F filers, Q2 2025 → Q3 2025: 256,051 shares bought and 151,213 shares sold, net +104,838 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Franklin Resources Inc. | 0.00% | No change | 189,894 | $412K |
| Stonepine Capital Management, LLC | 0.28% | Add +93.4% | 159,421 | $346K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 82,484 | $179K |
| Vanguard Group Inc. | 0.00% | Reduce -1.1% | 59,418 | $129K |
| Two Sigma Investments, LP | 0.00% | New | 49,453 | $107K |
| Two Sigma Advisers, LP | 0.00% | New | 45,751 | $99K |
| Jane Street Group, LLC | 0.00% | New | 26,182 | $57K |
| Citadel Advisors | 0.00% | New | 24,728 | $54K |
| Geode Capital Management, LLC | 0.00% | Add +2.5% | 19,292 | $42K |
| DRW Securities, LLC | 0.00% | New | 18,300 | $40K |
| XTX Topco Ltd | 0.00% | New | 12,492 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +101.4% | 3,055 | $7K |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -5.7% | 2,918 | $6K |
| BlackRock, Inc. | 0.00% | No change | 84 | $182 |
| Rockefeller Capital Management L.P. | 0.00% | New | 83 | $180 |
| Citigroup Inc. | 0.00% | New | 49 | $106 |
| Bank of America Corp. | 0.00% | Add +50.0% | 36 | $78 |
| UBS Group AG | 0.00% | Reduce -96.9% | 15 | $32 |
"% of holder's portfolio" is INAB's weight in each manager's 13F, not the share of IN8BIO Inc. the manager owns.